Cargando…
Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
BACKGROUND: ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. METHODS: 416 ICD patients with LVEF...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167949/ https://www.ncbi.nlm.nih.gov/pubmed/34058991 http://dx.doi.org/10.1186/s12872-021-02087-2 |
_version_ | 1783701791010979840 |
---|---|
author | Jiménez-Candil, Javier Duran, Olga Oterino, Armando Pérez, Jendri Castro, Juan Carlos Hernández, Jesús Moríñigo, José García, Manuel Sánchez Sánchez, Pedro L. |
author_facet | Jiménez-Candil, Javier Duran, Olga Oterino, Armando Pérez, Jendri Castro, Juan Carlos Hernández, Jesús Moríñigo, José García, Manuel Sánchez Sánchez, Pedro L. |
author_sort | Jiménez-Candil, Javier |
collection | PubMed |
description | BACKGROUND: ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. METHODS: 416 ICD patients with LVEF < 45% were studied. ICD programming was standardized. NSVT was defined as any VT of 5 or more beats at ≥ 150 bpm occurred in the first 6 months after implantation that terminated spontaneously and was not preceded by any appropriate therapy. The mean follow-up was 41 ± 27 months. RESULTS: We analyzed 2201 NSVTs (mean CL = 323 ms) that occurred in 250 patients; 111 of such episodes were fast (CL ≤ 300 ms). Secondary prevention (HR = 1.7; p < 0.001), number of NSVT episodes (HR = 1.05; 95% CI 1.04–1.07; p < 0.001) and beta-blocker treatment (HR = 0.7; p = 0.04) were independent predictors of appropriate interventions; however, the mean CL of NSVTs was not (p = 0.6). There was a correlation between the mean CL of NSVTs and the CL of the first monomorphic VT: r = 0.88; p < 0.001. This correlation was especially robust in individuals with > 5 NSVTs (r = 0.97; p < 0.001), with an agreement between both values greater than 95%. Patients with any fast NSVT experienced a higher incidence of VF episodes (26%) compared to those without NVSTs (3%) or with only slow NSVTs (7%); p < 0.001. CONCLUSIONS: Unlike the burden, the CL of NSVTs is not a predictor of subsequent appropriate interventions. However, there is a close relationship between the CL of NSVTs and that of arrhythmias that will later lead to appropriate therapies. |
format | Online Article Text |
id | pubmed-8167949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81679492021-06-02 Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies Jiménez-Candil, Javier Duran, Olga Oterino, Armando Pérez, Jendri Castro, Juan Carlos Hernández, Jesús Moríñigo, José García, Manuel Sánchez Sánchez, Pedro L. BMC Cardiovasc Disord Research BACKGROUND: ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. METHODS: 416 ICD patients with LVEF < 45% were studied. ICD programming was standardized. NSVT was defined as any VT of 5 or more beats at ≥ 150 bpm occurred in the first 6 months after implantation that terminated spontaneously and was not preceded by any appropriate therapy. The mean follow-up was 41 ± 27 months. RESULTS: We analyzed 2201 NSVTs (mean CL = 323 ms) that occurred in 250 patients; 111 of such episodes were fast (CL ≤ 300 ms). Secondary prevention (HR = 1.7; p < 0.001), number of NSVT episodes (HR = 1.05; 95% CI 1.04–1.07; p < 0.001) and beta-blocker treatment (HR = 0.7; p = 0.04) were independent predictors of appropriate interventions; however, the mean CL of NSVTs was not (p = 0.6). There was a correlation between the mean CL of NSVTs and the CL of the first monomorphic VT: r = 0.88; p < 0.001. This correlation was especially robust in individuals with > 5 NSVTs (r = 0.97; p < 0.001), with an agreement between both values greater than 95%. Patients with any fast NSVT experienced a higher incidence of VF episodes (26%) compared to those without NVSTs (3%) or with only slow NSVTs (7%); p < 0.001. CONCLUSIONS: Unlike the burden, the CL of NSVTs is not a predictor of subsequent appropriate interventions. However, there is a close relationship between the CL of NSVTs and that of arrhythmias that will later lead to appropriate therapies. BioMed Central 2021-05-31 /pmc/articles/PMC8167949/ /pubmed/34058991 http://dx.doi.org/10.1186/s12872-021-02087-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jiménez-Candil, Javier Duran, Olga Oterino, Armando Pérez, Jendri Castro, Juan Carlos Hernández, Jesús Moríñigo, José García, Manuel Sánchez Sánchez, Pedro L. Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies |
title | Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies |
title_full | Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies |
title_fullStr | Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies |
title_full_unstemmed | Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies |
title_short | Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies |
title_sort | cycle length of nonsustanied ventricular tachycardias among icd patients: implications on subsequent appropriate therapies |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167949/ https://www.ncbi.nlm.nih.gov/pubmed/34058991 http://dx.doi.org/10.1186/s12872-021-02087-2 |
work_keys_str_mv | AT jimenezcandiljavier cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies AT duranolga cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies AT oterinoarmando cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies AT perezjendri cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies AT castrojuancarlos cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies AT hernandezjesus cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies AT morinigojose cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies AT garciamanuelsanchez cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies AT sanchezpedrol cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies |